Strategic Partners A/S does not have significant operations (STRAP) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Strategic Partners A/S does not have significant operations stock DKK 274, price DKK 585, that is 53.2% below the price, quality 49 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Strategic Partners A/S does not have significant operations
STRAP · COOur calculation puts a fair price 53% below what the stock costs today.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 4, 2026.
How to read this chart
60‑month range kr 530.00 – kr 100,000 · fair‑value band kr 180.72 – kr 342.28 · the kr 585.00 price screens above the kr 273.82 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 4, 2026.
Every Wednesday you see whether Strategic Partners A/S does not have significant operations is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024.
Show moreShow less
Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.
Stock analysis
Strategic Partners A/S does not have significant operations (STRAP) currently trades at kr 585.00, while our model-based Fair Value estimate is kr 273.82, 53% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Scenario range: kr 180.72 (bear) to kr 342.28 (bull), the price of kr 585.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Strategic Partners A/S does not have significant operations reported revenue of 309K DKK in FY2025 versus 0 DKK in FY2020. Reported net income was −859K DKK in FY2025.
Key figures
Market cap 32.4M DKK (≈ $4.9M) Micro · P/E ratio 19.9 · EPS (TTM) kr 29.33 · Return on equity 7.2% · Return on assets (EBIT) −54.8% (5-year average) · Operating margin −927% · Revenue (TTM) 304K DKK · Revenue growth (YoY) −4.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 18 out of 100 (low confidence).
What moves the price
The share trades about 34% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 10% fair-value upside, at −53%, STRAP screens richer than that median.
Fair Value models
All 1 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Strategic Partners A/S does not have significant operations with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 558 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- P/E, EV/EBITDA and margins by industry (reference tables)
- EV/EBITDA by industry
- Dividend yield by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Healthcare
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Incyte Corporation INCY | $119.65 | $199.23 | +67% | vs STRAP |
| Regeneron Pharmaceuticals, Inc REGN | $904.35 | $1,275 | +41% | vs STRAP |
| Vertex Pharmaceuticals Incorporated VRTX | $547.09 | $601.80 | +10% | vs STRAP |
| Samsung Biologics Co 207940 | 1,516,000 KRW | 1,667,600 KRW | +10% | vs STRAP |
| Genmab A/S GMAB | kr 3,527 | kr 3,880 | +10% | vs STRAP |
| WuXi Biologics (Cayman) Inc 2269 | HK$47.62 | HK$52.38 | +10% | vs STRAP |
| argenx SE ARGX | $927.21 | $908.40 | −2% | vs STRAP |
| CSL Limited CSL | A$200.77 | A$183.04 | −9% | vs STRAP |
| Celltrion, Inc 068270 | 211,000 KRW | 74,945 KRW | −64% | vs STRAP |
| Royalty Pharma plc RPRX | $67.30 | $19.01 | −72% | vs STRAP |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Strategic Partners A/S does not have significant operations (STRAP) overvalued or undervalued?
What is the fair value of STRAP?
What is the quality score of STRAP?
What is the price target for Strategic Partners A/S does not have significant operations (STRAP)?
What is the Strategic Partners A/S does not have significant operations stock forecast for 2026?
What is the revenue of Strategic Partners A/S does not have significant operations (STRAP)?
What is the intrinsic value of Strategic Partners A/S does not have significant operations (STRAP)?
Is Strategic Partners A/S does not have significant operations stock overvalued or undervalued in 2026?
Is fair value the same as the market price of STRAP?
How much is Strategic Partners A/S does not have significant operations worth?
What do the bullish and bearish scenarios say about STRAP?
What is the P/E ratio of STRAP?
How solid is the balance sheet of Strategic Partners A/S does not have significant operations (STRAP)?
How far is STRAP from its 52-week high?
Which stocks are comparable to Strategic Partners A/S does not have significant operations?
Is Strategic Partners A/S does not have significant operations stock attractive at the current price?
How is the fair value of STRAP calculated?
Is it still worth investing in stocks now?
What is the share price of Strategic Partners A/S does not have significant operations (STRAP)?
What should I pay attention to with Strategic Partners A/S does not have significant operations right now?
Key figures of Strategic Partners A/S does not have significant operations
How large is the market capitalisation of Strategic Partners A/S does not have significant operations (STRAP)?
What are the earnings per share of Strategic Partners A/S does not have significant operations (STRAP)?
What is the return on equity of Strategic Partners A/S does not have significant operations (STRAP)?
What is the EBIT return on assets of Strategic Partners A/S does not have significant operations (STRAP)?
What is the operating margin of Strategic Partners A/S does not have significant operations (STRAP)?
How fast is revenue growing at Strategic Partners A/S does not have significant operations (STRAP)?
How much free cash flow does Strategic Partners A/S does not have significant operations (STRAP) generate?
How much net cash does Strategic Partners A/S does not have significant operations (STRAP) hold?
Watch Strategic Partners A/S does not have significant operations in the live analysis
One click puts Strategic Partners A/S does not have significant operations on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.